Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc (ENTA) Option Chain
As of September 25, 2026, Enanta Pharmaceuticals Inc is trading at $11.88, a -1.00% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 92.1%. IV Rank is 45%.
Read more
Tracking the ENTA option chain helps you see every strike and expiry on Enanta Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Enanta Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ENTA options activity at a glance. Use our scanner to monitor the ENTA option chain in real time and filter for the ENTA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ENTA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ENTA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ENTA stock options are being actively traded and where they are not.
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Enanta Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ENTA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ENTA stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile63.10% Neutral
- Market cap (M$)346
- 52 weeks high-30.73%
- 52 weeks low68.51%
- Analyst recommendationStrong Buy
1.17 - Target price$21.83
83.75% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-16
- P/E—
- Future P/E—
- EPS (ttm)-2.41
- EPS growth next 5 years11.43%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 2.28 | 0 | 0 | -0.03 | 4.38 | 2.40 | 6.30 | 7.50 | -36.87 | — | 0.05 | 0.00 | 0.05 | 0 | 1 | 97.72 |
| 24.62 | 0 | 0 | 0.27 | 1.88 | 0.20 | 4.10 | 10.00 | -15.82 | 0.10 | 0.70 | 0.00 | 0.40 | 208 | 140 | 75.38 |
| 62.97 | 257 | 0 | 2.50 | 0.00 | — | 2.50 | 12.50 | +5.22 | 0.45 | 2.00 | 0.62 | 0.61 | 0 | 9 | 37.03 |
| 87.75 | 10 | 0 | 0.80 | 0.00 | — | 0.80 | 15.00 | +26.26 | 1.25 | 5.10 | 3.12 | 0.06 | 0 | 3 | 12.25 |
| 96.90 | 11 | 0 | 1.40 | 0.00 | — | 1.40 | 17.50 | +47.31 | 3.70 | 7.60 | 5.62 | 0.03 | 0 | 0 | 3.10 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full ENTA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→